Studies of CD45+ and CD46+ expression on the peripheral blood lymphocyte subsets of the post-COVID patients

M. Dobrynina, A. Zurochka, M. Komelkova, S. Luo, V. Zurochka, H. Desheng, L. Ryabova, Alexey Sarapultsev
{"title":"Studies of CD45+ and CD46+ expression on the peripheral blood lymphocyte subsets of the post-COVID patients","authors":"M. Dobrynina, A. Zurochka, M. Komelkova, S. Luo, V. Zurochka, H. Desheng, L. Ryabova, Alexey Sarapultsev","doi":"10.46235/1028-7221-1160-soc","DOIUrl":null,"url":null,"abstract":"The SARS-CoV-2 virus can enter the cells using S1 viral spike (S) protein, not only by binding to ACE2, but also through other cellular receptors. These candidate receptors include CD46, which, like CD45, belongs to pan-leukocyte receptors and is expressed on all types of lymphocytes. In turn, SARS-CoV-2 infection is accompanied by damage to almost all compartments of the immune system, mainly T lymphocytes. The purpose of the study was to evaluate the expression levels of CD45+ and CD46+ in various subpopulations of lymphocytes in patients who had undergone SARS-CoV-2 infection. \n72 patients who had undergone SARS-CoV-2 infection were examined. Using flow cytometry technique, we determined CD45+ and CD46+ (panleukocyte marker for lymphocyte gating), CD45+ and CD46+, CD3+ (T lymphocytes), CD45+ and CD46+, CD3+, CD4+ (helper inducers), CD45+ and CD46+, CD3+, CD8+ (cytotoxic T-lymphocytes), CD45+ and CD46+, CD3+, CD56+ (TNK cells) CD45+ and CD46+, CD3-, CD56+ (natural killers), CD45+ and CD46+, CD3-, CD19+ (B lymphocytes), CD45+ and CD46+, CD3+, CD4+, CD25+ (activated helpers, early activation of lymphocytes), CD45+ and CD46+, CD3+, HLA-DR (activated T lymphocytes late activation of lymphocytes). Our studies have shown that a decrease in CD46+ expression in T lymphocytes (CD3+) is accompanied by similar decrease of its expression in cytotoxic T lymphocytes (CD3+, CD8+), TNK (CD3+, CD56+), as well as in helpers T carrying markers of early activation (CD3+, CD4+, CD25+). At the same time, the most pronounced decrease was observed both among total T lymphocytes and cytotoxic T cells. In these patients, the expression level of CD46+ in B lymphocytes was slightly increased. Recent data suggest that there is no involvement of CD46 receptor on B lymphocytes. Our data suggest that the SARS-CoV-2 virus may affect the CD46 receptor. Such exposure may lead to promotion of the long-COVID (post-COVID) symptoms in such patients, thus requiring new approaches to correction of these disorders.","PeriodicalId":21524,"journal":{"name":"Russian Journal of Immunology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Russian Journal of Immunology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46235/1028-7221-1160-soc","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The SARS-CoV-2 virus can enter the cells using S1 viral spike (S) protein, not only by binding to ACE2, but also through other cellular receptors. These candidate receptors include CD46, which, like CD45, belongs to pan-leukocyte receptors and is expressed on all types of lymphocytes. In turn, SARS-CoV-2 infection is accompanied by damage to almost all compartments of the immune system, mainly T lymphocytes. The purpose of the study was to evaluate the expression levels of CD45+ and CD46+ in various subpopulations of lymphocytes in patients who had undergone SARS-CoV-2 infection. 72 patients who had undergone SARS-CoV-2 infection were examined. Using flow cytometry technique, we determined CD45+ and CD46+ (panleukocyte marker for lymphocyte gating), CD45+ and CD46+, CD3+ (T lymphocytes), CD45+ and CD46+, CD3+, CD4+ (helper inducers), CD45+ and CD46+, CD3+, CD8+ (cytotoxic T-lymphocytes), CD45+ and CD46+, CD3+, CD56+ (TNK cells) CD45+ and CD46+, CD3-, CD56+ (natural killers), CD45+ and CD46+, CD3-, CD19+ (B lymphocytes), CD45+ and CD46+, CD3+, CD4+, CD25+ (activated helpers, early activation of lymphocytes), CD45+ and CD46+, CD3+, HLA-DR (activated T lymphocytes late activation of lymphocytes). Our studies have shown that a decrease in CD46+ expression in T lymphocytes (CD3+) is accompanied by similar decrease of its expression in cytotoxic T lymphocytes (CD3+, CD8+), TNK (CD3+, CD56+), as well as in helpers T carrying markers of early activation (CD3+, CD4+, CD25+). At the same time, the most pronounced decrease was observed both among total T lymphocytes and cytotoxic T cells. In these patients, the expression level of CD46+ in B lymphocytes was slightly increased. Recent data suggest that there is no involvement of CD46 receptor on B lymphocytes. Our data suggest that the SARS-CoV-2 virus may affect the CD46 receptor. Such exposure may lead to promotion of the long-COVID (post-COVID) symptoms in such patients, thus requiring new approaches to correction of these disorders.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
新冠肺炎后患者外周血淋巴细胞亚群CD45+和CD46+表达的研究
SARS-CoV-2病毒可以通过S1病毒刺突(S)蛋白进入细胞,不仅可以结合ACE2,还可以通过其他细胞受体进入细胞。这些候选受体包括CD46,它和CD45一样,属于泛白细胞受体,在所有类型的淋巴细胞上表达。反过来,SARS-CoV-2感染伴随着几乎所有免疫系统的损伤,主要是T淋巴细胞。本研究的目的是评估SARS-CoV-2感染患者不同淋巴细胞亚群中CD45+和CD46+的表达水平。对72例SARS-CoV-2感染患者进行了检查。利用流式细胞术技术,我们检测了CD45+和CD46+(淋巴细胞门控的泛白细胞标记物)、CD45+和CD46+、CD3+ (T淋巴细胞)、CD45+和CD46+、CD3+、CD8+(细胞毒性T淋巴细胞)、CD45+和CD46+、CD3+、CD56+ (TNK细胞)、CD45+和CD46+、CD3-、CD56+(自然杀伤细胞)、CD45+和CD46+、CD3-、CD19+ (B淋巴细胞)、CD45+和CD46+、CD3+、CD4+、CD25+(活化辅助细胞,早期活化淋巴细胞)、CD45+和CD46+、CD3+、CD4+、CD3+、CD45+和CD46+、CD3+、CD25+、CD45+和CD46+、CD3+、CD3+、CD25+(活化辅助细胞)、CD45+和CD46+、CD3+、CD3+、CD25+、CD45+和CD46+、HLA-DR(活化T淋巴细胞)。我们的研究表明,T淋巴细胞(CD3+)中CD46+表达的降低伴随着其在细胞毒性T淋巴细胞(CD3+, CD8+), TNK (CD3+, CD56+)以及辅助T携带早期激活标记(CD3+, CD4+, CD25+)中的表达的类似降低。同时,在总T淋巴细胞和细胞毒性T细胞中均观察到最明显的下降。在这些患者中,B淋巴细胞中CD46+的表达水平略有升高。最近的研究表明,B淋巴细胞上没有CD46受体的参与。我们的数据表明,SARS-CoV-2病毒可能影响CD46受体。这种暴露可能导致这些患者的长期covid(后covid)症状加剧,因此需要新的方法来纠正这些疾病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.40
自引率
0.00%
发文量
0
期刊最新文献
Effect of pregnancy-specific β1-glycoprotein on the expression of arginase-1 and indolamine-2,3-dioxygenase by myeloid-derived suppressor cells TLR-9 (-1237)*T/C polymorphism in russian COVID-19 patients from the chelyabinsk region Studies on the hormone and cytokine producing function of human cumulus cells and its interrelation with fertility in polycystic ovarian syndrome T helper subsets during the acute post-traumatic period in children Cytokine profile in adolescent children with recurrent infections and polypous rhinosinusitis, ways of their correction
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1